The top 10 companies leading in the development of biosimilar drugs include:
1. Pfizer
2. Novartis
3. Amgen
4. Celltrion
5. Samsung Bioepis
6. Teva Pharmaceuticals
7. Sandoz
8. Boehringer Ingelheim
9. Merck & Co.
10. Mylan
It’s important to note that the rankings may vary over time as the biosimilar market continues to evolve.
